CNTA — Centessa Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $6.19bn
- $6.03bn
- $15.00m
Brief: Centessa Pharmaceuticals Says Positive Topline Data From Proof-Of-Concept Study Of Serpinpc In Severe Hemophilia A & B Patients Not On Prophylaxis
Brief: Centessa Q2 Loss Per Share $0.65
U.S. STOCKS ON THE MOVE-Tech stocks, Splunk, Conn's, Westport
Centessa rises, caps robust week of IPOs
Brief: Centessa Pharmaceuticals Ltd Adss Open 1.25% Above IPO Price In Nasdaq Debut
General Atlantic-backed Centessa opens marginally above IPO price
NASDAQ RESUMED AT 11:46 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
Brief: Centessa Announces Pricing Of Initial Public Offering
General Atlantic-backed Centessa targets $1.7 bln valuation in U.S. IPO
Currently Estimated IPO Price Per ADS Will Be Between $18.00 And $20.00